kras g12v mutant advanced epithelial cancers
Showing 1 - 1 of 1
KRAS G12V Mutant Advanced Epithelial Cancers Trial (Cyclophosphamide, Gemcitabine, Pembrolizumab)
Available
- KRAS G12V Mutant Advanced Epithelial Cancers
- Cyclophosphamide
- +3 more
- (no location specified)
May 19, 2022